Sutro Biopharma Free Cash Flow Generation Index
Sutro Biopharma free cash flow generation index. Sutro Biopharma (STRO) has a Free Cash Flow Generation Index of 0.92x as of June 2024. Free cash flow of $8.70 Million represents 1% of operating cash flow ($9.46 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sutro Biopharma (2018–2022)
Free cash flow generation index of Sutro Biopharma from 2018 to 2022. Historical FCF Generation Index trend for Sutro Biopharma across 2 annual periods. See Sutro Biopharma free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Sutro Biopharma Free Cash Flow Generation Index by Year (2018–2022)
Sutro Biopharma free cash flow generation index by year from 2018 to 2022. Year-by-year Free Cash Flow Generation Index for Sutro Biopharma. For the full cash flow conversion analysis, see Sutro Biopharma (STRO) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.21x | $-4.31 Million | $3.55 Million | $7.86 Million | ▼ -238.4% |
| 2018 | 0.88x | $11.13 Million | $12.68 Million | $1.56 Million | — |